Cronos (CRON) Non-Current Deferred Tax Liability (2016 - 2026)

Cronos' (CRON) quarterly Non-Current Deferred Tax Liability came in at $4.0 million in Q1 2026, down 12.69% year-on-year from $4.6 million in Q1 2025, and down 2.57% quarter-over-quarter from $4.1 million in Q4 2025.

Cronos (CRON) Non-Current Deferred Tax Liability (2016 - 2026) Analysis & Trends

Cronos' Non-Current Deferred Tax Liability history runs 9 years deep, the most recent figure standing at $4.0 million for Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 12.69% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 12.69% decrease from a year earlier, with the FY2025 full-year figure at $4.1 million, up 14.73% from the prior year.
  • Non-Current Deferred Tax Liability fell to $4.0 million in Q1 2026 per CRON's latest filing, from $4.1 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $11.1 million in Q3 2024 and bottomed at $46000.0 in Q2 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $3.4 million (2025), against an average of $3.1 million.
  • Across the five-year window, Non-Current Deferred Tax Liability jumped 1869.06% in 2024 and sank 69.22% in 2025, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $1.9 million in 2022, then slumped by 90.56% to $181000.0 in 2023, then soared by 1869.06% to $3.6 million in 2024, then climbed by 14.73% to $4.1 million in 2025, then retreated by 2.57% to $4.0 million in 2026.
  • Per Business Quant, the three latest CRON Non-Current Deferred Tax Liability figures stand at $4.0 million (Q1 2026), $4.1 million (Q4 2025), and $3.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Cronos 1.08 Bn 261.26 Mn 19.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.98 Mn
Mar 31, 2026 3.98 Mn
Dec 31, 2025 4.09 Mn
Dec 31, 2025 4.09 Mn
Sep 30, 2025 3.43 Mn
Sep 30, 2025 3.43 Mn
Jun 30, 2025 5.54 Mn
Jun 30, 2025 5.54 Mn
Mar 31, 2025 4.56 Mn
Mar 31, 2025 4.56 Mn
Dec 31, 2024 3.56 Mn
Dec 31, 2024 3.56 Mn
Sep 30, 2024 11.14 Mn
Sep 30, 2024 11.14 Mn
Dec 31, 2023 181,000.00
Dec 31, 2023 181,000.00
Jun 30, 2023 675,000.00
Jun 30, 2023 675,000.00
Mar 31, 2023 378,000.00
Mar 31, 2023 378,000.00